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ABSTRACT 
Ultraviolet spectrophotometric and ion pair chromatographic methods have been developed for 
simultaneous estimation of telmisartan and hydrochlrothiazide from their tablet dosage form. The first 
method involves multiwavelength spectrophotometric estimation (Method 1) where interference due 
to hydrochlrothiazide at 286 nm (wavelength for estimation of telmisartan) was eliminated by 
recording absorbance difference at 286 nm and 308 nm whereas interference of telmisartan at 262 nm 
(wavelength for estimation of hydrochlrothiazide) was removed by recording absorbance difference 
at 262 nm and 282 nm. Linearity of the response was demonstrated by telmisartan in the 
concentration range of 5-35 µg/ml with a square correlation coefficient (r2) of 0.9995. Linearity of 
the response was demonstrated by hydrochlrothiazide in the concentration range of 3-21 µg/ml with a 
square correlation coefficient (r2) of 0.9992.  The second method utilizes ion pair chromatography 
(Method 2) on a HIQ sil ODS column (250 mm length x 4.6 mm internal diameter) using methanol: 
0.0025 M orthophosphoric acid (70:30 by volume pH 4.6) containing 0.1% 1-hexane sulphonic acid 
monohydrate sodium salt as mobile phase with UV detection at 259 nm over a concentration range of 
20-120 µg/ml for telmisartan and 12.5-75 µg/ml for hydrochlrothiazide. Losartan potassium was used 
as the internal standard. Both the methods were applied successfully for the analysis of the two drugs 
from their tablet dosage form. The results of analysis were validated statistically and as per ICHQ2B 
guidelines. The developed methods are simple, selective and reproducible and can be applied for 
routine analysis of formulations containing telmisartan and hydrochlrothiazide.  
 
KEYWORDS: Hydrochlorothiazide, Losartan Potassium, Multiwavelength Method, RP-
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1. Introduction 
Telmisartan (TEL) is a angiotensin II receptor blocker. Chemically TEL is 4’-[(1,4
1
-
Dimethyl-2’-propyl[2,6’-bi-1H-benzimidazole]-1’-yl)methyl]-[1,1’-biphenyl]-2-carbox- -ylic 
acid 
1
. Several analytical methods such as difference spectrometry
2
, immunoassay 
development 3  liquid chromatography-tandam mass sprectrometry 
3-6
, HPLC 
7-9
,
 
micellar 
electrokinetic chromatographic method 
10
 , capillary zone electophoresis 
11-12
 , , linear sweep 
polarography 
13
 , are reported for estimation of TEL from their respective single dosage 
forms and biological fluids. Hydrochlrothiazide (HYD) chemically known as 6-Chloro-3,4-
dihydro-2H-1,2,4-benzothiadiazine-7- sulfonamide-1,1-dioxide, is a diuretic and is useful in 
the treatment of mild to moderate essential hypertension .The drug is reported in Indian 
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pharmacopoeia (1996),
 
British Pharmacopoeia (1993), and United State pharmacopoeia 
(1995 3
rd
 ed.) 
14-16
 . A survey of literature revealed different analytical methods including 
Gas chromatography-mass spectrometric method 
17
 , electrochemical method 
18 
, time 
resolved chemiluminence 
19 
, micellar electrokinetic method 
20
 , High Performance Liquid 
Chromatography 
21-23
 etc for estimation of HYD from its pharmaceutical dosage form and 
biological fluid. Few spectrophotometric 
24-25
 methods have also been reported for estimation 
of hydrochlorothiazide from their tablet dosage form with ramipril and Losartan (LOS). Fix 
dose combination containing TEL and HYD is available in tablet dosage form in market. 
Two methods RP- High Performance Liquid Chromatography and High Performance Thin 
Layer Chromatography methods are reported for the simultaneous estimation of TEL and 
HYD from their combined dosage forms 
26-27
. In the present work an attempt has been made 
to develop and validate a simple, sensitive and reproducible spectrophotometric method and 
ion pair chromatographic method with greater precision, accuracy, and sensitivity for the 
quality control and routine analysis of TEL and HYD in tablet dosage form. 
 
 
 
  
                                      
          Telmisartan                                                     Hydrochlorothiazide 
Chemical structure of telmisartan and hydrochlorthiazide 
2. EXPERIMENTAL  
2.1. Apparatus 
a) A PC based Jasco V-530 recording spectrophotometer with spectral bandwidth 
(resolution) of 2 nm and wavelength accuracy ± 0.3 nm (with automatic wavelength 
correction) was employed for all measurements using a matched pair of 10mm quartz cell. 
b) The HPLC system was a PC based Jasco series comprising of a pump PU-2080 
and a UV-2070 detector. Manual injections were carried out using a Rheodyne injector with 
a fixed 20 µl external loop. The chromatographic separations were performed on a 5 µm HIQ 
sil ODS column (250 mm length x 4.6 mm internal diameter), operating at ambient 
temperature, using a mobile phase consisting of methanol: 0.0025 M orthophosphoric acid 
(70:30 by volume pH 4.6) containing 0.1% 1-hexane sulphonic acid monohydrate sodium 
salt). 
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c) Shimadzu AY 120 analytical balance was used for weighing.  
d) PCi Ultrasonicator was used for sonication. 
2.2. Materials   
2.2.1. Pure samples 
TEL and HYD were kindly supplied by Glenmark Ltd., Nashik and Macloide pharma 
Ltd., Mumbai, India. respectively. The purity given as % purity ± SD was found to be 100.65 
± 0.71 and 99.23 ± 0.82 respectively for TEL and HYD.   
2.2.2. Market samples 
Marketed sample of TEL and HYD (Telsar H) in their combined tablet dosage form 
of Merck Limited Aurangabad, India. Batch No. A 6011WB was used for analysis. Each 
tablet contained 40 mg of TEL and 12.5 mg of HYD. 
2.2.3. Chemical and reagents 
For spectrophotometric work methanol (Loba chemie Pvt. Ltd. Mumbai, India) of 
spectroscopic grade was used. For HPLC work double distilled water was prepared in 
laboratory. Methanol, Orthophosphoric acid and 1-hexane sulphonic acid monohydrate 
sodium salt (Loba chemie Pvt. Ltd. Mumbai, India) of HPLC grade were used. 
2.3. Preparation of standard and sample solutions  
2.3.1. Standard stock solutions 
For spectrophotometric method standard stock solutions of TEL and HYD (1000 
µg/ml each of TEL and HYD) were prepared by weighing accurately 100 mg of TEL and 
HYD separately into two 100 ml volumetric flasks and dissolved in 40 ml of methanol. The 
mixture was sonicated for 10 minutes and volume was made up to 100 ml with the same 
solvent. 
For HPLC method standard stock solutions containing TEL was prepared by 
transferring 100 mg of TEL into 50 ml volumetric flask. It was then dissolved in 30 ml of 
methanol, ultrasonicated for 10 minutes and the final volume of the solution was made up to 
50 ml with methanol to get stock solution containing 2000 µg/ml of TEL. 50 mg of HYD 
was separately weighed and transferred into another 50 ml volumetric flask. It was dissolved 
in 40 ml methanol and ultrasonicated for 10 minutes. The final volume of the solution was 
made up to 50 ml with methanol to get stock solution containing 1000 µg/ml of HYD. 
LOS was selected as an internal standard. Standard stock solution containing LOS 
was prepared by dissolving 5 mg of LOS in 40 ml of methanol in a 50 ml volumetric flask. It 
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was then ultrasonicated for 10 minutes and then final volume of solution was made up to 50 
ml with methanol to get 100 µg/ml of LOS. 
2.3.2. Working solutions 
From the stock solutions 1 ml of the TEL and HYD standard stock solution were 
transferred in two separate 100 ml volumetric flasks and diluted to the mark with methanol to 
get a final concentration of 100 µg/ml
 
each of TEL and HYD for the spectrophotometric 
work.  
For HPLC method, 50 ml of the Standard stock solutions containing TEL was 
transferred into separate 100 ml volumetric flask and 10 ml of HYD were transferred into 
separate 100 ml volumetric flasks and diluted to the mark with methanol to get a final 
concentration of 1000 µg/ml of TEL and 100 µg/ml HYD.  
2.4. Laboratory prepared mixtures 
2.4.1. For calibration curve of spectrophotometric method 
Accurate aliquots of TEL and HYD were transferred from working solutions (100 
µg/ml) into a series of seven 10 ml volumetric flasks and volume was made up to the mark 
with methanol. Seven mixed standard solutions containing concentrations of 5-35 µg/ml of 
TEL and 3-21 µg/ml
 
of HYD were obtained. 
2.4.2. For calibration curve of HPLC method 
In to a series of six 10 ml volumetric flasks, appropriate aliquots from working 
solutions of TEL (1000 µg/ml) and HYD (100 µg/ml) were pipetted and to each flask 2 ml of 
(100 µg/ml) LOS as internal standard was added and then final volume of all the solutions 
was made up to 10 ml with methanol. Six mixed standard solutions containing 20-120 µg/ml 
of TEL and 12.5-75 µg/ml
 
of HYD with each mixed standard containing 20 µg/ml of LOS 
were obtained. 
2.5. Procedures of Analysis 
2.5.1. For multiwavelength method 
2.5.1.1. Linearity 
Absorption spectras of seven mixed standard solutions prepared as above were 
recorded in the range of 200-400 nm with scanning speed of 1000 nm/min, 1.0 nm data pitch 
and 2 nm bandwidth against methanol as blank. Calibration curve for TEL was constructed 
against concentration by taking absorbance differences at 286 and 308 nm from the spectra 
of mixed standards whereas the calibration curve for HYD was constructed against 
concentration by taking absorbance differences at 262 and 282 nm. The data of regression 
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equations is given in table 8. 
2.5.1.2. Assay of laboratory-prepared mixtures 
 Absorption spectras of different laboratory-prepared mixtures containing different 
concentrations of the two drugs were recorded. For the determination of concentration of the 
TEL absorbance difference was recorded at 286 and 308 nm whereas for determination of 
concentration of HYD absorbance difference was noted at 262 and 282 nm. The 
concentration of each drug was calculated from the corresponding regression equation. The 
results of analysis (n = 9) are given in Table 1. 
2.5.1.3. Assay of marketed pharmaceutical preparation (Telsar H tablet) 
A commercially available tablet formulation containing TEL 40 mg and HYD 12.5 
mg was analyzed using this method. Twenty tablets were accurately weighed and average 
weight was calculated. These tablets were ground to a fine powder and an accurately 
weighed tablet powder equivalent to 10 mg of TEL was transferred to a 100 ml volumetric 
flask and to this 6 mg of pure HYD was added. 60 ml of methanol was added to the flask. 
The solution was then sonicated for 10 min at 25 
0
C, filtered through whatmann filter paper 
No.41 and the volume was made up to 100 ml with methanol. The solution was analysed 
using the method described under assay of laboratory-prepared mixtures (as in 3.5.1.2.).  
2.5.2. For HPLC method 
2.5.2.1. Linearity 
The mixed standard solutions as prepared above (3.4.2.) were run on chromatographic 
system. A 20 µl of sample solution was injected into the chromatographic system using fixed 
volume loop injector and chromatograms were recorded. The flow rate was maintained at 1 
ml/min at ambient temperature and all the elluents were monitored at 259 nm. The separation 
was done on a C18 column using methanol: 0.0025 M orthophosphoric acid (70:30 by 
volume pH 4.6) containing 0.1% of 1-hexane sulphonic acid monohydrate sodium salt. 
Calibration curves for both TEL and HYD were plotted against concentration by calculating 
response factor at 259 nm and the corresponding regression equations were generated. The 
overlain chromatograms are represented in Fig. 8 and the data of regression equations is 
given in table 8. 
2.5.2.2. Analysis of laboratory-prepared mixtures 
Chromatograms of different laboratory-prepared mixtures containing different 
concentrations of the two drugs were recorded. The similar chromatographic conditions were 
applied for each laboratory-prepared mixtures and the concentrations of TEL and HYD were 
calculated by substituting in the regression equations. The results of analysis (n = 9) are 
reported in table 4. 
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2.5.2.3. Analysis of marketed pharmaceutical preparation (Telsar H tablet) 
From the triturate of 20 tablets, an amount equivalent to 40 mg of TEL and 12.5 mg 
of HYD was weighed, transferred to a 25 ml volumetric flask and dissolved in 20 ml 
methanol. It was then ultrasonicated for 10 minutes. The solution was filtered through 0.22 µ 
membrane filter and then final volume of the solution was made up to 25 ml with methanol. 
Appropriate aliquots within the Beer’s law limit were withdrawn into 10 ml volumetric flasks 
and to each of them 2 ml of (100 µg/ml) LOS was added as internal standard. The volume 
was made up to the mark with methanol and analyzed by the proposed method using the 
procedure described above (3.5.2.2.). The concentration of TEL and HYD present in the 
sample solution was calculated by using regression equation generated from calibration curve 
of respective drugs. The results of analysis   (n = 9) are reported in table 4.   
3. Results and Discussion 
The development of an analytical method for simultaneous estimation of drugs 
without previous chemical separation in multicomponent pharmaceutical formulations has 
received considerable attention in recent years because of its importance in quality control of 
drugs and drug products.  
This work is devoted for the analysis of TEL and HYD which is available together in 
the form of tablets. Therefore the aim of this work was to develop simple analytical methods 
for the simultaneous determination of TEL and HYD. This was achieved by development of 
one multiwavelength spectrophotometric and one ion pair chromatographic method.  
3.1. Spectrophotometric method (Method 1) 
Multiwavelength absorption spectrophotometric method was developed for analysis 
of TEL and HYD. The method utilizes seven mixed standard solutions involving scanning at 
286, 308, 262 and 282 nm as sampling wavelengths. From the overlain spectra of two drugs 
(Fig. 1) it was noted that there is no wavelength over the scanning range of 200 to 400 nm 
where TEL can be accurately quantified without substantial interference of HYD. Thus 
quantification of TEL was achieved by taking the absorbance difference at 286 and 308 nm. 
Similarly there is no wavelength over the scanning range of 200 to 400 nm where HYD can 
be accurately quantified without substantial interference of TEL. Thus quantification of HYD 
was achieved by taking the absorbance difference at 262 nm and 282 nm. Overlain spectra of 
individual drugs and mixed standards are shown in Fig. 1 and 2. 
The results of quantitative determination of TEL and HYD in tablets were found in 
good agreement with the labeled amount of both the drugs (Table 1). % Relative standard 
deviation for the determination of TEL and HYD was found to be 1.05 and 1.04. Regression 
analysis for multiwavelength spectrophotometric method (Table 8), the linearity of the 
calibration graph (Fig. 3 and 4) and adherence of the method to Beer’s law was confirmed by 
high value of the square correlation coefficient (r
2
), 0.9995 and 0.9992 for TEL and HYD 
respectively.  
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Closeness of the amount found to the labelled amount and the low coefficient of 
variation value showed that the proposed method was accurate and precise. Spiking 
Accuracy of analysis was determined performed a recovery study conducted by the proposed 
spectrophotometric method by performing recovery studies by spiking different 
concentrations of pure drug in the pre-analyzed tablet sample. The results of the recovery 
analysis are represented in Table 2. High recoveries obtained as 100.40 ± 0.83 and 99.53 ± 
0.67 (% recovery ± standard deviation) with low standard deviation confirmed the suitability 
of the proposed method for the determination of TEL and HYD respectively in tablet 
formulation.  
3.2. Ion pair chromatographic method (Method 2) 
An Ion pair chromatographic method was developed for estimation of TEL and HYD 
which can be conveniently employed for routine quality control in pharmaceutical dosage 
forms. The chromatographic conditions were optimized in order to provide a good 
performance of the assay. To achieve the simultaneous elution of the two components under 
isocratic condition, different chromatographic conditions (organic modifier, flow rate, ionic 
strength, pH) were investigated. RP-HPLC system consisting of HIQ sil ODS column (250 
mm length x 4.6 mm internal diameter) provided good resolution for separation of TEL and 
HYD. Mobile phases containing methanol alone or acetonitrile alone were found to elute the 
two compounds unresolved.  Various ratios of Methanol: acetonirtrile: water was found to 
produce the chromatograms with very close retention times and poor resolution. Mobile 
phase consisting of methanol:water (70:30 by volume) separated the two components but 
produced tailing effect with a broad peak of TEL. Best resolution was achieved at the mobile 
phase composition of methanol: 0.0025 M orthophosphoric acid (70:30 by volume pH 4.6) 
containing 0.1% 1-hexane sulphonic acid monohydrate sodium salt where the peaks of 
telmisartan and hydrochlorothiazide were clearly resolved with sharp peaks of both the 
drugs. Losartan potassium (LOS) was used as internal standard. It was found to be a suitable 
internal standard for this study under the selected chromatographic conditions.  
Flow rate of 0.5 ml/min. resulted in greater retention times and 1.2 ml/min. resulted in 
very close retention times with poor resolution. A flow rate of 1 ml/min. resulted in elution 
of all drugs within 10 minutes with retention times of 2.77, 4.93, 6.82, for HYD, LOS and 
TEL respectively. Chromatogram of laboratory prepared mixture is shown in Fig.5 while 
optical characteristics are shown in Table 8.  
The sampling wavelength was selected after scanning the drug solutions in the mobile 
phase having concentration of 25 µg/ml in the UV range of 200 – 400 nm on a UV 
spectrophotometer. 259 nm was selected as suitable wavelength for estimation. A six-point 
calibration curve was constructed with working standards and was found linear as shown by 
correlation coefficient (r
2
) ≥ 0.9973, 0.9986 for TEL and HYD respectively over their 
calibration ranges (Fig. 9 and 10). The results of tablet analysis show that the method was 
specific, as none of the excipients interfered with the analytes of interest (Fig. 6). The 
method was thus suitably employed for assaying the commercial formulation containing TEL 
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and HYD.  
The proposed method was applied to the determination of TEL and HYD in their 
pharmaceutical dosage form. The results indicate satisfactory accuracy and precision of the 
method. The statistical data obtained after replicate determinations (n = 9) is shown in Table 
4. The % recovery ± S. D. (n = 9) of the added TEL and HYD (Fig. 7) was found to be 
101.22 ± 1.08 and 101.73 ± 1.06, respectively (Table 5).  
3.3. Method Validation 
Both the methods were validated for precision, accuracy, repeatability, limit of 
detection and limit of quantitation as per ICHQ2B guidelines and also statistically. The 
precision and accuracy were determined with standard quality control samples (in addition to 
calibration standards) prepared in triplicates at different concentration levels covering the 
entire linearity range. Precision is the degree of repeatability of an analytical method under 
normal operational conditions. The precision of the assay was determined by repeatability 
(intra-day) and intermediate precision (inter-day) and reported as %R.S.D. The intermediate 
precision was studied by comparing the assays on two different days and the results 
documented as standard deviation and %R.S.D. Accuracy is the percent of analyte recovered 
by assay from a known added amount. Accuracy of analysis was determined by performing 
recovery studies by using spiked concentrations of pure drug in the pre-analyzed tablet 
sample solution. Data from nine determinations over four concentration levels covering the 
specified range was determined. Results of inter-day and intra-day precision of method 1 and 
method 2 are given in table 3 and 6 respectively.  
The limit of detection (LOD) is defined as the lowest concentration of an analyte that 
an analytical process can reliably differentiate from background levels. The limit of 
quantitation (LOQ) is defined as the lowest concentration of the standard curve that can be 
measured with acceptable accuracy, precision and variability. The LOD and LOQ were 
calculated as (Given in Table 7),  LOD = 3.3σ/ S, and LOQ = 10σ/ S, Where σ is the standard 
deviation of the lowest standard concentration and S is the slope of the calibration curve. An 
appropriate number of blank samples (9 determinations) were scanned in the selected range 
and the standard deviations of these responses were calculated. Low LOD and LOQ for TEL 
and HYD respectively for both the methods shows the high sensitivity of the method. 
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